Do Patents Affect Outcomes in Early Stage Investing?
In conducting due diligence for early stage companies, we often consider a company’s portfolio of patents and/or patents pending. If the idea behind the company
Facility, Accelerator and Soft Landing programs powering biotech innovation.
F3 Tech supports late-stage companies in the AgTech, CyberAg, Renewable Energy and AgBioTech sectors with advanced business advisory services. The program is an initiative of the Eastern Shore Entrepreneurship Center and supported by the U.S. Economic Development Administration.
Our pilot-scale biomanufacturing facility gives startups enterprise-level labs and equipment to refine processes, validate products, and accelerate commercialization—bridging the “innovation valley of death” and enabling globally competitive solutions.
Our six-month accelerator moves later-stage startups from proven innovation to market impact with mentorship, technical guidance, and investor access. With alumni raising $100M+ in follow-on funding, it prepares companies to scale, secure customers, and attract strategic partners.
Our Soft Landing program helps international and national startups enter the U.S. market with lab space, mentorship, and direct connections to investors, institutions, and policymakers. Located near D.C. and key regulatory agencies, it reduces barriers and de-risks expansion into the U.S. biotech landscape.
The aim of our industry collaboration program is to coordinate the needs of leading sector sponsors with that of equally impressive innovators. Industry needs innovative solutions to remain competitive. Innovators need collaboration with industry to focus discovery.
F3 Tech portfolio companies have attracted over $105 million in follow-on investment since 2018.
The U.S. Economic Development Administration has awarded $2.5 million in funding to support F3 Tech’s accelerator and biomanufacturing initiatives.
F3 Tech’s portfolio of 26 companies generates an aggregate of $80M+ in annual revenue in sales.
In conducting due diligence for early stage companies, we often consider a company’s portfolio of patents and/or patents pending. If the idea behind the company
A Perspective from the OEM Industry Leaving behind the initial peak of inflated expectations while following the well-known Gartner hype cycle into its corresponding disillusionment
On January 10th and 12th, the F3 Tech SEDI Program Director and Program Administrator held a Lunch and Learn Town Hall for the stakeholders from
Be the company that advances while others stall.